Acculi Labs funding, investors and company details

Acculi Labs is an emerging Healthcare startup from Bengaluru, working in the space of Healthtech firm specializing in non-invasive diagnostics through its Lyfas mobile platform. Founded by Rupam Das, Hari Prasath M.

Company: Acculi Labs Private Limited
Sector: Healthcare
Location: Bengaluru
Founders: Rupam Das, Hari Prasath M
Total funding raised: ₹427.74 Cr

Company overview

Acculi Labs operates as a healthtech firm specializing in non-invasive diagnostics through its Lyfas mobile platform, capturing psychophysiological biomarkers via smartphone cameras for early detection of conditions like hypertension, atherosclerosis, diabetic cardiovascular autonomic neuropathy, endothelial dysfunction, and sympathetic dominance. Core activities include developing AI-driven analysis for sleep quality, psycho-physiological stress, metabolic and pulmonary systems, muscle function, and blood biochemistry from 3-5 minute tests; generating detailed clinician reports with quantitative health assessments; enabling remote monitoring for immunity, viral load, female emotional health, PCOS, and chronic diseases; and supporting point-of-care screening, predictive insights, and therapy recommendations via integrated apps and JVs for scalable preventive healthcare.

Funding rounds

Latest round (Seed): $ 51.00 Mn (₹427.74 Cr.), 2024-08-01. Investors: Sabi Holding India Limited